Transforming growth factor-β1 gene C-509T and T869C polymorphisms as possible risk factors in rheumatic heart disease in Egypt

References

• Carapetis JR. The current evidence for the burden of group A streptococcal diseases. Geneva, World Health Organization 2004; 1–57.
   Google Scholar
• Mayosi BM, Robertson K, Volmink J, Adebo W, Akinyore K, Amoah A, Bannerman C, Biesman-Simons S, Carapetis J, Cilliers A, Commerford P. Croasdale A, Damasceno A, Dean J, Dean M, de Souza R, Filipe A, Hugo-Hamman C, Jurgens-Clur SA, Kombila-Koumba P, Kotzenberg C, Lawrenson J, Manga P, Matenga J, Mathivha T, Mntla P, Mocumbi A, Mokone T, Ogola E, Omokhodion S, Palweni C, Pearce A, Salo A, Thomas B, Walker K, Wiysonge C, Zaher S. The Drakensberg Declaration on the control of rheumatic fever and rheumatic heart disease in Africa. S Afr Med J 2006; 96: 246.
   Google Scholar
• Kemeny E, Grieve T, Marcus R, Sareli P, Zabriskie JB. Identification of mononuclear cells and T cell subsets in rheumatic valvulitis. Clin Immunol Immunopathol 1989; 52: 225–37.
   Google Scholar
• Guilherme L, Cury P, Demarchi LM, Coelho V, Abel L, Lopez AP, Oshiro SE, Aliotti S, Cunha-Neto E, Pomer-antzeff PM, Tanaka AC, Kalil J. Rheumatic heart disease: proinflammatory cytokines play a role in the progression and maintenance of valvular lesions. Am J Pathol 2004; 165: 1583–91.
   Google Scholar
• Fraser WJ, Haffejee Z, Jankelow D, Wadee A, Cooper K. Rheumatic Aschoff nodules revisited. II: Cytokine expres-sion corroborates recently proposed sequential stages. Histopathology 1997; 31: 460–4.
   Google Scholar
• Wen FQ, Liu X, Kobayashi T, Abe S, Fang Q, Kohyama T, Ertl R, Terasaki Y, Manouilova L, Rennard SI. Interferon-gamma inhibits transforming growth factor-beta production in human airway epithelial cells by targeting Smads. Am J Respir Cell Mol Biol 2004; 30: 816–22.
   Google Scholar
• Guilherme L, Weidebach W, Kiss MH, Snitcowsky R, Kalil J. Association of human leukocyte class II antigens with rheumatic fever or rheumatic heart disease in a Brazilian population. Circulation 1991; 83: 1995–8.
   Google Scholar
• Carlquist JF, Ward RH, Meyer KJ, Husebye D, Feolo M, Anderson JL. Immune response factors in rheumatic heart disease: meta-analysis of HLA-DR associations and evalu-ation of additional class II alleles. J Am Coll Cardiol 1995; 26: 452–7.
   Google Scholar
• Ignotz R, Massague J. Transforming growth factor-fl stim-ulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 1986; 261: 4337–45.
   Google Scholar
• Laiho M, Saksela O, Keski-Oja J. Transforming growth factor-fl induction of type-1 plasminogen activator inhibitor. J Biol Chem 1987; 262: 17467–74.
   Google Scholar
• Mutsaers SE, Bishop JE, McGrouther G, Laurent GJ. Mech-anisms of tissue repair: from wound healing to fibrosis. Int .1 Biochem Cell Biol 1997; 29: 5–17.
   Google Scholar
• Jian B, Narula N, Li QY, Mohler ER 3rd, Levy RJ. Progres-sion of aortic valve stenosis: TGF-fil is present in calcified aortic valve cusps and promotes aortic valve interstitial cell calcification via apoptosis. Ann Thorac Surg 2003; 75: 457–65.
   Google Scholar
• Jian B, Connolly J, Savani RC, Narula N, Liang B, Levy R. Serotonin mechanisms in heart valve disease I: Serotonin-induced up-regulation of transforming growth factor-betal via G-protein signal transduction in aortic valve interstitial cells. Am J Pathol 2002; 161: 2111–21.
   Google Scholar
• Ng CM, Cheng A, Myers LA, Martinez-Murillo F, Jie C, Bedja D, Gabrielson KL, Hausladen JM, Mecham RP, Judge DP, Dietz HC. TGF beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome. J Clin Invest 2004; 114: 1586–92.
   Google Scholar
• Walker GA, Masters KS, Shah DN, Anseth KS, Leinwand LA. Valvular myofibroblast activation by transforming growth factor-beta: implications for pathological extracellu-lar matrix remodeling in heart valve disease. Circ Res 2004; 95: 253–60.
   Google Scholar
• Lijnen P, Petrov V. Transforming growth factor-beta 1-induced collagen production in cultures of cardiac fibmblasts is the result of the appearance of myofibroblasts. Methods Find Exp Clin Pharmacol 2002; 24: 333–44.
   Google Scholar
• Khan R, Sheppard R. Fibrosis in heart disease: under-standing the role of transforming growth factor-1 in cardio-myopathy, valvular disease, and arrhythmia. Immunology 2006; 118: 10–24.
   Google Scholar
• Kim L, Kim do K, Yang WI, Shin DH, Jung IM, Park HK, Chang BC. Overexpression of transforming growth factor-beta 1 in the valvular fibrosis of chronic rheumatic heart disease. J Korean Med Sci 2008; 23: 41–8.
   Google Scholar
• Dunning AM, Ellis PD, McBride S, Kirschenlohr HL, Healey CS, Kemp PR, Luben RN, Chang-Claude J, Man-nermaa A, Kataja V, Pharoah PD, Easton DF, Ponder BA, Metcalfe JC. A transforming growth factor beta 1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer. Cancer Res 2003; 63: 2610–15.
   Google Scholar
• Yokota M, Ichihara S, Lin TL, Nakashima N, Yamada Y Association of a T29->C polymorphism of the transforming growth factor-/fl gene with genetic susceptibility to myocar-dial infarction in Japanese. Circulation 2000; 101: 2783–7.
   Google Scholar
• Chou HT, Chen CH, Tsai CH, Tsai FJ. Association between transforming growth factor-beta 1 gene C-509T and T869C polymorphisms and rheumatic heart disease. Am Heart J 2004; 148: 181–6.
   Google Scholar
• Lu LY, Cheng HH, Sung PK, Yeh JJ, Shiue YL, Chen A. Single-nucleotide polymorphisms of transforming growthfactor-beta 1 gene in Taiwanese patients with systemic lupus erythematosus. J Microbiol Immunol Infect 2004; 37: 145–52.
   Google Scholar
• Shah R, Rahaman B, Hurley CK, Posch PE. Allelic diver-sity in the TGF-B 1 regulatory region: characterization of novel functional single nucleotide polymorphisms. Hum Genet 2006; 119: 61–74.
   Google Scholar
• Hoffmann SC, Stanley EM, Cox ED, DiMercurio BS, Koziol DE, Harlan DM, Kirk AD, Blair PJ. Ethnicity greatly influences cytokine gene polymorphism distribution. Am J Transplant 2002; 2: 560–7.
   Google Scholar
• Crow, JF. Hardy, Weinberg and language impediments. Genetics 1999; 152: 821–5.
   Google Scholar
• Veasy LG, Hill HR. Immunologic and clinical correlations in rheumatic fever and rheumatic heart disease. Pediatr Infect Dis J 1997; 16: 400–7.
   Google Scholar
• Yamada H, Watanabe M, Nanba T, Akamizu T, Iwatani Y The + 869T/C polymorphism in the transforming growth factor-/fl gene is associated with the severity and intractabil-ity of autoimmune thyroid disease. Clin Exp Immunol 2008; 151: 379–82.
   Google Scholar
• Xaubet A, Marin-Arguedas A, Lario S, Ancochea J, Morell F, Ruiz-Manzano J, Rodriguez-Becerra E, Rodriguez-Arias JM, Inigo P, Sanz S, Campistol JM, Mullol J, Picado C. Transforming growth factor-betal gene polymorphisms are associated with disease progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2003; 168: 431–5.
   Google Scholar
• Sugiura Y, Niimi T, Sato S, Yoshinouchi T, Banno S, Naniwa T, Maeda H, Shimizu S, Ueda R. Transforming growth factor betal gene polymorphism in rheumatoid arthritis. Ann Rheum Dis 2002; 61: 826–8.
   Google Scholar
• Cambien F, Ricard S, Troesch A, Mallet C, Générénaz L, Evans A, Arveiler D, Luc G, Ruidavets JB, Poirier O. Poly-morphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Témoin de l’Infarctus du Myocarde (ECTIM) Study. Hypertension 1996; 28: 881–7.
   Google Scholar
• Awad MR, El-Gamel A, Hasleton P, Turner DM, Sinnott PJ, Hutchinson IV. Genotypic variation in the transforming growth factor-/fl gene. Transplantation 1998; 66: 1014–20.
   Google Scholar
• Grainger DJ, Heathcote K, Chiano M, Snieder H, Kemp PR, Metcalfe JC, Carter ND, Spector TD. Genetic control of the circulating concentration of transforming growth factor type beta 1 . Hum Mol Genet 1999; 8: 93–7.
   Google Scholar